{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:50:32Z","timestamp":1781913032581,"version":"3.54.5"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:00:00Z","timestamp":1751068800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"NIH\/NIGMS","award":["T32GM008361"],"award-info":[{"award-number":["T32GM008361"]}]},{"name":"NIH\/NIGMS","award":["T32GM008361"],"award-info":[{"award-number":["T32GM008361"]}]},{"name":"O\u2019Neal Invests Young Supporters Board","award":["Postdoctoral NextGen Scholars Award"],"award-info":[{"award-number":["Postdoctoral NextGen Scholars Award"]}]},{"name":"NIH\/NINDS","award":["1T32NS121721-01A1"],"award-info":[{"award-number":["1T32NS121721-01A1"]}]},{"name":"NIH\/NINDS","award":["R01NS134798"],"award-info":[{"award-number":["R01NS134798"]}]},{"name":"NIH\/NCI","award":["R01CA236911"],"award-info":[{"award-number":["R01CA236911"]}]},{"name":"NIH\/NCI","award":["R01CA258248"],"award-info":[{"award-number":["R01CA258248"]}]},{"name":"NIH\/NCI","award":["U01CA223976"],"award-info":[{"award-number":["U01CA223976"]}]},{"name":"NIH\/NHLBI","award":["R01HL168659"],"award-info":[{"award-number":["R01HL168659"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02057-1","type":"journal-article","created":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:18:05Z","timestamp":1751066285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Xenoline-polarized macrophages as an alternative in vitro model of tumor-associated macrophages in glioblastoma"],"prefix":"10.1186","volume":"13","author":[{"given":"Hasan","family":"Alrefai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"Elkholy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor L.","family":"Schanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia H.","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun-Young Erin","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ryan","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Willey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,28]]},"reference":[{"key":"2057_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2011\u20132015. Neuro Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"2057_CR2","doi-asserted-by":"publisher","unstructured":"A, O, LM D (11\/06\/ (2013) Glioblastoma and other malignant gliomas: a clinical review - PubMed. JAMA 310. https:\/\/doi.org\/10.1001\/jama.2013.280319","DOI":"10.1001\/jama.2013.280319"},{"key":"2057_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jocn.2012.01.060","volume":"20","author":"L Dorner","year":"2013","unstructured":"Dorner L, Mustafa A, Rohr A, Mehdorn HM, Nabavi A (2013) Growth pattern of tumor recurrence following bis-chloroethylnitrosourea (BCNU) wafer implantation in malignant glioma. J Clin Neurosci 20:429\u2013434. https:\/\/doi.org\/10.1016\/j.jocn.2012.01.060","journal-title":"J Clin Neurosci"},{"key":"2057_CR4","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1200\/JCO.2008.19.4969","volume":"27","author":"AA Brandes","year":"2009","unstructured":"Brandes AA, Tosoni A, Franceschi E, Sotti G, Frezza G, Amista P, Morandi L, Spagnolli F, Ermani M (2009) Recurrence pattern after Temozolomide concomitant with and adjuvant to radiotherapy in newly diagnosed patients with glioblastoma: correlation with MGMT promoter methylation status. J Clin Oncol 27:1275\u20131279. https:\/\/doi.org\/10.1200\/JCO.2008.19.4969","journal-title":"J Clin Oncol"},{"key":"2057_CR5","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1016\/j.ejca.2012.04.011","volume":"48","author":"R Stupp","year":"2012","unstructured":"Stupp R, Wong ET, Kanner AA, Steinberg D, Engelhard H, Heidecke V, Kirson ED, Taillibert S, Liebermann F, Dbaly Vet al et al (2012) NovoTTF-100A versus physician\u2019s choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality. Eur J Cancer 48:2192\u20132202. https:\/\/doi.org\/10.1016\/j.ejca.2012.04.011","journal-title":"Eur J Cancer"},{"key":"2057_CR6","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, Dewhirst MW, Bigner DD, Rich JN (2006) Glioma stem cells promote radioresistance by Preferential activation of the DNA damage response. Nature 444:756\u2013760. https:\/\/doi.org\/10.1038\/nature05236","journal-title":"Nature"},{"key":"2057_CR7","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, Parada LF (2012) A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 488:522\u2013526. https:\/\/doi.org\/10.1038\/nature11287","journal-title":"Nature"},{"key":"2057_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1093\/neuonc\/nov244","volume":"18","author":"KE van der Vos","year":"2016","unstructured":"van der Vos KE, Abels ER, Zhang X, Lai C, Carrizosa E, Oakley D, Prabhakar S, Mardini O, Crommentuijn MH, Skog Jet al et al (2016) Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia\/macrophages in the brain. Neuro Oncol 18:58\u201369. https:\/\/doi.org\/10.1093\/neuonc\/nov244","journal-title":"Neuro Oncol"},{"key":"2057_CR9","doi-asserted-by":"publisher","unstructured":"Ciccocioppo F, Lanuti P, Marchisio M, Miscia S (2020) Extracellular vesicles involvement in the modulation of the glioblastoma environment. J Oncol 2020(3961735). https:\/\/doi.org\/10.1155\/2020\/3961735","DOI":"10.1155\/2020\/3961735"},{"key":"2057_CR10","doi-asserted-by":"publisher","first-page":"96","DOI":"10.3390\/cells9010096","volume":"9","author":"ER Matarredona","year":"2019","unstructured":"Matarredona ER, Pastor AM (2019) Extracellular Vesicle-Mediated communication between the glioblastoma and its microenvironment. Cells 9:96. https:\/\/doi.org\/10.3390\/cells9010096","journal-title":"Cells"},{"key":"2057_CR11","doi-asserted-by":"publisher","first-page":"14556","DOI":"10.1038\/s41598-021-93775-8","volume":"11","author":"S Valdebenito","year":"2021","unstructured":"Valdebenito S, Malik S, Luu R, Loudig O, Mitchell M, Okafo G, Bhat K, Prideaux B, Eugenin EA (2021) Tunneling nanotubes, TNT, communicate glioblastoma with surrounding non-tumor astrocytes to adapt them to hypoxic and metabolic tumor conditions. Sci Rep 11:14556. https:\/\/doi.org\/10.1038\/s41598-021-93775-8","journal-title":"Sci Rep"},{"key":"2057_CR12","doi-asserted-by":"publisher","unstructured":"Chang AL, Miska J, Wainwright DA, Dey M, Rivetta CV, Yu D, Kanojia D, Pituch KC, Qiao J, Pytel P et al (2016) CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells. Cancer Res 76: 5671\u20135682 https:\/\/doi.org\/10.1158\/0008-5472.CAN-16-0144","DOI":"10.1158\/0008-5472.CAN-16-0144"},{"key":"2057_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ana.10679","volume":"54","author":"M Platten","year":"2003","unstructured":"Platten M, Kretz A, Naumann U, Aulwurm S, Egashira K, Isenmann S, Weller M (2003) Monocyte chemoattractant protein-1 increases microglial infiltration and aggressiveness of gliomas. Ann Neurol 54:388\u2013392. https:\/\/doi.org\/10.1002\/ana.10679","journal-title":"Ann Neurol"},{"key":"2057_CR14","doi-asserted-by":"publisher","first-page":"519","DOI":"10.2119\/molmed.2011.00217","volume":"18","author":"SJ Coniglio","year":"2012","unstructured":"Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, Segall JE (2012) Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling. Mol Med 18:519\u2013527. https:\/\/doi.org\/10.2119\/molmed.2011.00217","journal-title":"Mol Med"},{"key":"2057_CR15","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.2147\/JIR.S357787","volume":"15","author":"W Gao","year":"2022","unstructured":"Gao W, Li Y, Zhang T, Lu J, Pan J, Qi Q, Dong S, Chen X, Su Z, Li J (2022) Systematic analysis of chemokines reveals CCL18 is a prognostic biomarker in glioblastoma. J Inflamm Res 15:2731\u20132743. https:\/\/doi.org\/10.2147\/JIR.S357787","journal-title":"J Inflamm Res"},{"key":"2057_CR16","doi-asserted-by":"publisher","unstructured":"Tomassetti C, Insinga G, Gimigliano F, Morrione A, Giordano A, Giurisato E (2024) Insights into CSF-1R expression in the tumor microenvironment. Biomedicines 12. https:\/\/doi.org\/10.3390\/biomedicines12102381","DOI":"10.3390\/biomedicines12102381"},{"key":"2057_CR17","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1038\/nm.3337","volume":"19","author":"SM Pyonteck","year":"2013","unstructured":"Pyonteck SM, Akkari L, Schuhmacher AJ, Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT, Teijeiro Vet al et al (2013) CSF-1R Inhibition alters macrophage polarization and blocks glioma progression. Nat Med 19:1264\u20131272. https:\/\/doi.org\/10.1038\/nm.3337","journal-title":"Nat Med"},{"key":"2057_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/neuonc\/nov272","volume":"18","author":"JH Stafford","year":"2016","unstructured":"Stafford JH, Hirai T, Deng L, Chernikova SB, Urata K, West BL, Brown JM (2016) Colony stimulating factor 1 receptor Inhibition delays recurrence of glioblastoma after radiation by altering myeloid cell recruitment and polarization. Neuro Oncol 18:797\u2013806. https:\/\/doi.org\/10.1093\/neuonc\/nov272","journal-title":"Neuro Oncol"},{"key":"2057_CR19","doi-asserted-by":"publisher","first-page":"62425","DOI":"10.18632\/oncotarget.11515","volume":"7","author":"W Chen","year":"2016","unstructured":"Chen W, Xia T, Wang D, Huang B, Zhao P, Wang J, Qu X, Li X (2016) Human astrocytes secrete IL-6 to promote glioma migration and invasion through upregulation of cytomembrane MMP14. Oncotarget 7:62425\u201362438. https:\/\/doi.org\/10.18632\/oncotarget.11515","journal-title":"Oncotarget"},{"key":"2057_CR20","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1038\/labinvest.3700482","volume":"86","author":"D Zagzag","year":"2006","unstructured":"Zagzag D, Lukyanov Y, Lan L, Ali MA, Esencay M, Mendez O, Yee H, Voura EB, Newcomb EW (2006) Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion. Lab Invest 86:1221\u20131232. https:\/\/doi.org\/10.1038\/labinvest.3700482","journal-title":"Lab Invest"},{"key":"2057_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/neuonc\/noq082","volume":"12","author":"A Wu","year":"2010","unstructured":"Wu A, Wei J, Kong LY, Wang Y, Priebe W, Qiao W, Sawaya R, Heimberger AB (2010) Glioma cancer stem cells induce immunosuppressive macrophages\/microglia. Neuro Oncol 12:1113\u20131125. https:\/\/doi.org\/10.1093\/neuonc\/noq082","journal-title":"Neuro Oncol"},{"key":"2057_CR22","doi-asserted-by":"publisher","first-page":"3585","DOI":"10.1007\/s11033-010-0469-4","volume":"38","author":"B Qiu","year":"2011","unstructured":"Qiu B, Zhang D, Wang C, Tao J, Tie X, Qiao Y, Xu K, Wang Y, Wu A (2011) IL-10 and TGF-beta2 are overexpressed in tumor spheres cultured from human gliomas. Mol Biol Rep 38:3585\u20133591. https:\/\/doi.org\/10.1007\/s11033-010-0469-4","journal-title":"Mol Biol Rep"},{"key":"2057_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.yexcr.2010.02.018","volume":"316","author":"J Held-Feindt","year":"2010","unstructured":"Held-Feindt J, Hattermann K, Muerkoster SS, Wedderkopp H, Knerlich-Lukoschus F, Ungefroren H, Mehdorn HM, Mentlein R (2010) CX3CR1 promotes recruitment of human glioma-infiltrating microglia\/macrophages (GIMs). Exp Cell Res 316:1553\u20131566. https:\/\/doi.org\/10.1016\/j.yexcr.2010.02.018","journal-title":"Exp Cell Res"},{"key":"2057_CR24","doi-asserted-by":"publisher","first-page":"174216","DOI":"10.1016\/j.ejphar.2021.174216","volume":"905","author":"CK Shen","year":"2021","unstructured":"Shen CK, Huang BR, Yeh WL, Chen CW, Liu YS, Lai SW, Tseng WP, Lu DY, Tsai CF (2021) Regulatory effects of IL-1beta in the interaction of GBM and tumor-associated monocyte through VCAM-1 and ICAM-1. Eur J Pharmacol 905:174216. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174216","journal-title":"Eur J Pharmacol"},{"key":"2057_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/bph.12008","volume":"168","author":"YT Yeung","year":"2013","unstructured":"Yeung YT, McDonald KL, Grewal T, Munoz L (2013) Interleukins in glioblastoma pathophysiology: implications for therapy. Br J Pharmacol 168:591\u2013606. https:\/\/doi.org\/10.1111\/bph.12008","journal-title":"Br J Pharmacol"},{"key":"2057_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.canlet.2011.11.001","volume":"316","author":"VF Zhu","year":"2012","unstructured":"Zhu VF, Yang J, Lebrun DG, Li M (2012) Understanding the role of cytokines in glioblastoma multiforme pathogenesis. Cancer Lett 316:139\u2013150. https:\/\/doi.org\/10.1016\/j.canlet.2011.11.001","journal-title":"Cancer Lett"},{"key":"2057_CR27","doi-asserted-by":"publisher","first-page":"e94188","DOI":"10.1371\/journal.pone.0094188","volume":"9","author":"MR Fernando","year":"2014","unstructured":"Fernando MR, Reyes JL, Iannuzzi J, Leung G, McKay DM (2014) The pro-inflammatory cytokine, interleukin-6, enhances the polarization of alternatively activated macrophages. PLoS ONE 9:e94188. https:\/\/doi.org\/10.1371\/journal.pone.0094188","journal-title":"PLoS ONE"},{"key":"2057_CR28","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2020.00835","volume":"11","author":"W Fu","year":"2020","unstructured":"Fu W, Wang W, Li H, Jiao Y, Huo R, Yan Z, Wang J, Wang S, Wang J, Chen D al (2020) Single-Cell atlas reveals complexity of the immunosuppressive microenvironment of initial and recurrent glioblastoma. Front Immunol 11:835. https:\/\/doi.org\/10.3389\/fimmu.2020.00835","journal-title":"Front Immunol"},{"key":"2057_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.it.2021.02.004","volume":"42","author":"W Xuan","year":"2021","unstructured":"Xuan W, Lesniak MS, James CD, Heimberger AB, Chen P (2021) Context-Dependent Glioblastoma-Macrophage\/Microglia symbiosis and associated mechanisms. Trends Immunol 42:280\u2013292. https:\/\/doi.org\/10.1016\/j.it.2021.02.004","journal-title":"Trends Immunol"},{"key":"2057_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1093\/neuonc\/noz185","volume":"22","author":"J de Groot","year":"2020","unstructured":"de Groot J, Penas-Prado M, Alfaro-Munoz K, Hunter K, Pei BL, O\u2019Brien B, Weathers SP, Loghin M, Kamiya Matsouka C, Yung WKA al (2020) Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages. Neuro Oncol 22:539\u2013549. https:\/\/doi.org\/10.1093\/neuonc\/noz185","journal-title":"Neuro Oncol"},{"key":"2057_CR31","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s11864-019-0619-4","volume":"20","author":"T McGranahan","year":"2019","unstructured":"McGranahan T, Therkelsen KE, Ahmad S, Nagpal S (2019) Current state of immunotherapy for treatment of glioblastoma. Curr Treat Options Oncol 20:24. https:\/\/doi.org\/10.1007\/s11864-019-0619-4","journal-title":"Curr Treat Options Oncol"},{"key":"2057_CR32","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/s1471-4906(02)02302-5","volume":"23","author":"A Mantovani","year":"2002","unstructured":"Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23:549\u2013555. https:\/\/doi.org\/10.1016\/s1471-4906(02)02302-5","journal-title":"Trends Immunol"},{"key":"2057_CR33","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ejca.2006.01.003","volume":"42","author":"A Sica","year":"2006","unstructured":"Sica A, Schioppa T, Mantovani A, Allavena P (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer 42:717\u2013727. https:\/\/doi.org\/10.1016\/j.ejca.2006.01.003","journal-title":"Eur J Cancer"},{"key":"2057_CR34","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1186\/s12885-015-1546-9","volume":"15","author":"M Genin","year":"2015","unstructured":"Genin M, Clement F, Fattaccioli A, Raes M, Michiels C (2015) M1 and M2 macrophages derived from THP-1 cells differentially modulate the response of cancer cells to Etoposide. BMC Cancer 15:577. https:\/\/doi.org\/10.1186\/s12885-015-1546-9","journal-title":"BMC Cancer"},{"key":"2057_CR35","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1093\/neuonc\/noae139","volume":"26","author":"P Gupta","year":"2024","unstructured":"Gupta P, Dang M, Oberai S, Migliozzi S, Trivedi R, Kumar G, Peshoff M, Milam N, Ahmed A, Bojja K al (2024) Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas. Neuro Oncol 26:2239\u20132255. https:\/\/doi.org\/10.1093\/neuonc\/noae139","journal-title":"Neuro Oncol"},{"key":"2057_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1038\/s41593-020-00789-y","volume":"24","author":"AR Pombo Antunes","year":"2021","unstructured":"Pombo Antunes AR, Scheyltjens I, Lodi F, Messiaen J, Antoranz A, Duerinck J, Kancheva D, Martens L, De Vlaminck K, Hove Het al et al (2021) Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization. Nat Neurosci 24:595\u2013610. https:\/\/doi.org\/10.1038\/s41593-020-00789-y","journal-title":"Nat Neurosci"},{"key":"2057_CR37","doi-asserted-by":"publisher","unstructured":"Abdelfattah N, Kumar P, Wang C, Leu JS, Flynn WF, Gao R, Baskin DS, Pichumani K, Ijare OB, Wood SL et al (2022) Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target. Nat Commun 13: 767 https:\/\/doi.org\/10.1038\/s41467-022-28372-y","DOI":"10.1038\/s41467-022-28372-y"},{"key":"2057_CR38","doi-asserted-by":"publisher","first-page":"eabg9518","DOI":"10.1126\/sciadv.abg9518","volume":"7","author":"JW Opzoomer","year":"2021","unstructured":"Opzoomer JW, Anstee JE, Dean I, Hill EJ, Bouybayoune I, Caron J, Muliaditan T, Gordon P, Sosnowska D, Nuamah Ret al et al (2021) Macrophages orchestrate the expansion of a proangiogenic perivascular niche during cancer progression. Sci Adv 7:eabg9518. https:\/\/doi.org\/10.1126\/sciadv.abg9518","journal-title":"Sci Adv"},{"key":"2057_CR39","doi-asserted-by":"publisher","unstructured":"Khan S, Mahalingam R, Sen S, Martinez-Ledesma E, Khan A, Gandy K, Lang FF, Sulman EP, Alfaro-Munoz KD Majd NK (2021) intrinsic interferon signaling regulates the cell death and mesenchymal phenotype of glioblastoma stem cells. Cancers (Basel) 13: https:\/\/doi.org\/10.3390\/cancers13215284","DOI":"10.3390\/cancers13215284"},{"key":"2057_CR40","doi-asserted-by":"publisher","unstructured":"Ravi VM, Neidert N, Will P, Joseph K, Maier JP, Kuckelhaus J, Vollmer L, Goeldner JM, Behringer SP Scherer F (2022) T-cell dysfunction in the glioblastoma microenvironment is mediated by myeloid cells releasing interleukin-10. Nat Commun 13: 925 https:\/\/doi.org\/10.1038\/s41467-022-28523-1","DOI":"10.1038\/s41467-022-28523-1"},{"key":"2057_CR41","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12967-023-03883-4","volume":"21","author":"Y Zhou","year":"2023","unstructured":"Zhou Y, Xiao D, Jiang X, Nie C (2023) EREG is the core onco-immunological biomarker of Cuproptosis and mediates the cross-talk between VEGF and CD99 signaling in glioblastoma. J Transl Med 21:28. https:\/\/doi.org\/10.1186\/s12967-023-03883-4","journal-title":"J Transl Med"},{"key":"2057_CR42","doi-asserted-by":"publisher","first-page":"vdad009","DOI":"10.1093\/noajnl\/vdad009","volume":"5","author":"P Sharma","year":"2023","unstructured":"Sharma P, Aaroe A, Liang J, Puduvalli VK (2023) Tumor microenvironment in glioblastoma: current and emerging concepts. Neurooncol Adv 5:vdad009. https:\/\/doi.org\/10.1093\/noajnl\/vdad009","journal-title":"Neurooncol Adv"},{"key":"2057_CR43","doi-asserted-by":"publisher","unstructured":"Stackhouse CT, Anderson JC, Yue Z, Nguyen T, Eustace NJ, Langford CP, Wang J, Rowland JRt, Xing C Mikhail FM (2022) an in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases. JCI Insight 7: e148717 https:\/\/doi.org\/10.1172\/jci.insight.148717","DOI":"10.1172\/jci.insight.148717"},{"key":"2057_CR44","doi-asserted-by":"publisher","unstructured":"Osuka S, Zhu D, Zhang Z, Li C, Stackhouse CT, Sampetrean O, Olson JJ, Gillespie GY, Saya H Willey CD (2021) N-cadherin upregulation mediates adaptive radioresistance in glioblastoma. J Clin Invest 131: e136098 https:\/\/doi.org\/10.1172\/JCI136098","DOI":"10.1172\/JCI136098"},{"key":"2057_CR45","doi-asserted-by":"publisher","first-page":"viii324","DOI":"10.1093\/neuonc\/noae165.1289","volume":"26","author":"H Alrefai","year":"2024","unstructured":"Alrefai H, Elkholy A, Lin B, Kumar M, Schanel T, Nassour-Caswell L, Anderson J, Hicks P, Ahn E, Miller CR al (2024) Tmod-25. Utilizing primary macrophages as an improved Serum-Free in vitro model of Tumor-Associated macrophages in glioblastoma. Neurooncology 26:viii324\u2013viii325. https:\/\/doi.org\/10.1093\/neuonc\/noae165.1289","journal-title":"Neurooncology"},{"key":"2057_CR46","doi-asserted-by":"publisher","unstructured":"Eustace NJ, Anderson JC, Warram JM, Widden HN, Pedersen RT, Alrefai H, Patel Z, Hicks PH, Placzek WJ Gillespie GY (2020) A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma. Oncogene 39: 6961\u20136974 https:\/\/doi.org\/10.1038\/s41388-020-01511-9","DOI":"10.1038\/s41388-020-01511-9"},{"key":"2057_CR47","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.3171\/2019.7.JNS191376","volume":"133","author":"AN Ibrahim","year":"2020","unstructured":"Ibrahim AN, Yamashita D, Anderson JC, Abdelrashid M, Alwakeal A, Estevez-Ordonez D, Komarova S, Markert JM, Goidts V, Willey CD al (2020) Intratumoral Spatial heterogeneity of BTK Kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor. J Neurosurg 133:1683\u20131694. https:\/\/doi.org\/10.3171\/2019.7.JNS191376","journal-title":"J Neurosurg"},{"key":"2057_CR48","doi-asserted-by":"publisher","first-page":"vi220","DOI":"10.1093\/neuonc\/noab196.882","volume":"23","author":"H Alrefai","year":"2021","unstructured":"Alrefai H, Beierle A, Nassour L, Eustace N, Patel Z, Anderson J, Hicks P, King P, Willey C (2021) Tmod-21. A novel in-Vitro method to model macrophages in glioblastoma. Neurooncology 23:vi220\u2013vi220. https:\/\/doi.org\/10.1093\/neuonc\/noab196.882","journal-title":"Neurooncology"},{"key":"2057_CR49","doi-asserted-by":"publisher","first-page":"v305","DOI":"10.1093\/neuonc\/noad179.1181","volume":"25","author":"H Alrefai","year":"2023","unstructured":"Alrefai H, Kumar M, Nassour L, Schanel T, Beierle A, Anderson J, Hicks P, Willey C (2023) Modl-30. Utilizing Serum-Free Co-Culture models for in-Vitro modeling of Tumor-Associated macrophages in glioblastoma. Neurooncology 25:v305\u2013v305. https:\/\/doi.org\/10.1093\/neuonc\/noad179.1181","journal-title":"Neurooncology"},{"key":"2057_CR50","doi-asserted-by":"publisher","unstructured":"Gabrusiewicz K, Li X, Wei J, Hashimoto Y, Marisetty AL, Ott M, Wang F, Hawke D, Yu J, Healy LM et al (2018) Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes. Oncoimmunology 7: e1412909 https:\/\/doi.org\/10.1080\/2162402X.2017.1412909","DOI":"10.1080\/2162402X.2017.1412909"},{"key":"2057_CR51","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1038\/s41467-020-16827-z","volume":"11","author":"W Tao","year":"2020","unstructured":"Tao W, Chu C, Zhou W, Huang Z, Zhai K, Fang X, Huang Q, Zhang A, Wang X, Yu X al (2020) Dual role of WISP1 in maintaining glioma stem cells and tumor-supportive macrophages in glioblastoma. Nat Commun 11:3015. https:\/\/doi.org\/10.1038\/s41467-020-16827-z","journal-title":"Nat Commun"},{"key":"2057_CR52","doi-asserted-by":"publisher","first-page":"e0153550","DOI":"10.1371\/journal.pone.0153550","volume":"11","author":"M Zhang","year":"2016","unstructured":"Zhang M, Hutter G, Kahn SA, Azad TD, Gholamin S, Xu CY, Liu J, Achrol AS, Richard C, Sommerkamp Pet al et al (2016) Anti-CD47 treatment stimulates phagocytosis of glioblastoma by M1 and M2 polarized macrophages and promotes M1 polarized macrophages in vivo. PLoS ONE 11:e0153550. https:\/\/doi.org\/10.1371\/journal.pone.0153550","journal-title":"PLoS ONE"},{"key":"2057_CR53","doi-asserted-by":"publisher","unstructured":"Gabrusiewicz K, Rodriguez B, Wei J, Hashimoto Y, Healy LM, Maiti SN, Thomas G, Zhou S, Wang Q, Elakkad A et al (2016) Glioblastoma-infiltrated innate immune cells resemble M0 macrophage phenotype. JCI Insight 1: https:\/\/doi.org\/10.1172\/jci.insight.85841","DOI":"10.1172\/jci.insight.85841"},{"key":"2057_CR54","doi-asserted-by":"publisher","unstructured":"Rynikova M, Adamkova P, Hradicka P, Stofilova J, Harvanova D, Matejova J, Demeckova V (2023) Transcriptomic analysis of macrophage polarization protocols: vitamin D(3) or IL-4 and IL-13 do not polarize THP-1 monocytes into reliable M2 macrophages. Biomedicines 11. https:\/\/doi.org\/10.3390\/biomedicines11020608","DOI":"10.3390\/biomedicines11020608"},{"key":"2057_CR55","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/cr.2010.52","volume":"20","author":"Q Wang","year":"2010","unstructured":"Wang Q, Ni H, Lan L, Wei X, Xiang R, Wang Y (2010) Fra-1 protooncogene regulates IL-6 expression in macrophages and promotes the generation of M2d macrophages. Cell Res 20:701\u2013712. https:\/\/doi.org\/10.1038\/cr.2010.52","journal-title":"Cell Res"},{"key":"2057_CR56","doi-asserted-by":"publisher","unstructured":"Duluc D, Delneste Y, Tan F, Moles MP, Grimaud L, Lenoir J, Preisser L, Anegon I, Catala L, Ifrah N et al (2007) Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells. Blood 110: 4319\u20134330 https:\/\/doi.org\/10.1182\/blood-2007-02-072587","DOI":"10.1182\/blood-2007-02-072587"},{"key":"2057_CR57","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1177\/1753425919876690","volume":"26","author":"S Gholamin","year":"2020","unstructured":"Gholamin S, Youssef OA, Rafat M, Esparza R, Kahn S, Shahin M, Giaccia AJ, Graves EE, Weissman I, Mitra Set al et al (2020) Irradiation or Temozolomide chemotherapy enhances anti-CD47 treatment of glioblastoma. Innate Immun 26:130\u2013137. https:\/\/doi.org\/10.1177\/1753425919876690","journal-title":"Innate Immun"},{"key":"2057_CR58","doi-asserted-by":"publisher","first-page":"167449","DOI":"10.1016\/j.bbadis.2024.167449","volume":"1870","author":"C Ma","year":"2024","unstructured":"Ma C, Chen J, Ji J, Zheng Y, Liu Y, Wang J, Chen T, Chen H, Chen Z, Zhou Q al (2024) Therapeutic modulation of APP-CD74 axis can activate phagocytosis of TAMs in GBM. Biochim Biophys Acta Mol Basis Dis 1870:167449. https:\/\/doi.org\/10.1016\/j.bbadis.2024.167449","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2057_CR59","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1002\/path.1711030410","volume":"103","author":"H Fraser","year":"1971","unstructured":"Fraser H (1971) Astrocytomas in an inbred mouse strain. J Pathol 103:266\u2013270. https:\/\/doi.org\/10.1002\/path.1711030410","journal-title":"J Pathol"},{"key":"2057_CR60","doi-asserted-by":"publisher","unstructured":"Riva M, Wouters R, Weerasekera A, Belderbos S, Nittner D, Thal DR, Baert T, Giovannoni R, Gsell W, Himmelreich U et al (2019) CT-2A neurospheres-derived high-grade glioma in mice: a new model to address tumor stem cells and immunosuppression. Biol Open 8: https:\/\/doi.org\/10.1242\/bio.044552","DOI":"10.1242\/bio.044552"},{"key":"2057_CR61","doi-asserted-by":"publisher","unstructured":"Johanns TM, Ward JP, Miller CA, Wilson C, Kobayashi DK, Bender D, Fu Y, Alexandrov A, Mardis ER, Artyomov MN et al (2016) Endogenous Neoantigen-Specific CD8 T Cells Identified in Two Glioblastoma Models Using a Cancer Immunogenomics Approach. Cancer Immunol Res 4: 1007\u20131015 https:\/\/doi.org\/10.1158\/2326-6066.CIR-16-0156","DOI":"10.1158\/2326-6066"},{"key":"2057_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijrobp.2012.12.025","volume":"86","author":"J Zeng","year":"2013","unstructured":"Zeng J, See AP, Phallen J, Jackson CM, Belcaid Z, Ruzevick J, Durham N, Meyer C, Harris TJ, Albesiano Eet al et al (2013) Anti-PD-1 Blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas. Int J Radiat Oncol Biol Phys 86:343\u2013349. https:\/\/doi.org\/10.1016\/j.ijrobp.2012.12.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2057_CR63","doi-asserted-by":"publisher","unstructured":"Zhai L, Ladomersky E, Dostal CR, Lauing KL, Swoap K, Billingham LK, Gritsina G, Wu M, McCusker RH, Binder DC et al (2017) Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4\/PD-L1 inhibition in mouse glioblastoma. Brain Behav Immun 62: 24\u201329 https:\/\/doi.org\/10.1016\/j.bbi.2017.01.022","DOI":"10.1016\/j.bbi.2017.01.022"},{"key":"2057_CR64","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/neuonc\/now179","volume":"19","author":"J Hardcastle","year":"2017","unstructured":"Hardcastle J, Mills L, Malo CS, Jin F, Kurokawa C, Geekiyanage H, Schroeder M, Sarkaria J, Johnson AJ, Galanis E (2017) Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody Blockade enhances antitumor activity in glioblastoma treatment. Neuro Oncol 19:493\u2013502. https:\/\/doi.org\/10.1093\/neuonc\/now179","journal-title":"Neuro Oncol"},{"key":"2057_CR65","doi-asserted-by":"publisher","first-page":"3508","DOI":"10.4049\/jimmunol.1200662","volume":"189","author":"G Zizzo","year":"2012","unstructured":"Zizzo G, Hilliard BA, Monestier M, Cohen PL (2012) Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol 189:3508\u20133520. https:\/\/doi.org\/10.4049\/jimmunol.1200662","journal-title":"J Immunol"},{"key":"2057_CR66","doi-asserted-by":"publisher","first-page":"761901","DOI":"10.3389\/fonc.2021.761901","volume":"11","author":"S de Mey","year":"2021","unstructured":"de Mey S, Dufait I, De Ridder M (2021) Radioresistance of human cancers: clinical implications of genetic expression signatures. Front Oncol 11:761901. https:\/\/doi.org\/10.3389\/fonc.2021.761901","journal-title":"Front Oncol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02057-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02057-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:18:06Z","timestamp":1751066286000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02057-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,28]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2057"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02057-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6567445\/v1","asserted-by":"object"}]},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,28]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki and was approved by the UAB Institutional Review Board. Approved protocols include IRB-300002910, IRB-300004965, IRB-300011400, and IRB-300011400-003.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors indicate no direct conflicts of interest for the manuscript but for full disclosure: CDW has received funding from AACR-Novocure, Varian Medical Systems, and OMS Foundation and has been a consultant and\/or received honorarium from EMD Serono, LifeNet Health, and Guidepoint Global.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"137"}}